{"title": "Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany", "doi": "10.1101/2020.03.21.20040154", "citation_id": "2020.03.21.20040154v1", "date": "2020-03-24", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.21.20040154", "abstract": "<p>We model the COVID-19 coronavirus epidemic in South Korea, Italy, France, and Germany. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting  social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.</p>", "twitter_description": "We model the COVID-19 coronavirus epidemic in South Korea, Italy, France, and Germany. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNo funding\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nThe Data are coming from WHO.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.21.20040154v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.21.20040154v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.21.20040154v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/24/2020.03.21.20040154.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.21.20040154v1", "access_rights": "restricted", "authors": ["pierre magal", "Glenn Webb"]}